A SINGLE CENTER RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY BETWEEN LOW-DOSE VERSUS HIGH-DOSE RITUXIMAB AS REMISSION INDUCTION THERAPY IN JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

被引：0
|
作者：
Hirose, Kei [1 ]
Hirata, Manami [1 ]
Yamamura, Yuriko [1 ]
Ueno, Akiko [1 ]
Yamamura, Masahiro [1 ]
机构：
[1] Okayama Saiseikai Gen Hosp, Ctr Rheumatol, Okayama, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.4450
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0590
引用
收藏
页码：1756 / 1756
页数：1
相关论文
共 50 条
  • [1] A Single Center Retrospective Analysis of Efficacy and Safety Between Low-Dose versus High-Dose Rituximab as Remission Induction Therapy with ANCA-Associated Vasculitis
    Hirose, Kei
    Hirata, Manami
    Ueno, Akiko
    Yamamura, Masahiro
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] LOW-DOSE RITUXIMAB AS INDUCTION THERAPY FOR JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Takakuwa, Y.
    Hanaoka, H.
    Kiyokawa, T.
    Ishimori, K.
    Iida, H.
    Nagafuchi, H.
    Okazaki, T.
    Ozaki, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1260 - 1260
  • [3] COMPARISON OF EFFICACY AND SAFETY BETWEEN RITUXIMAB AND CYCLOPHOSPHAMIDE IN REMISSION INDUCTION THERAPY FOR JAPANESE ANCA-ASSOCIATED VASCULITIS(AAV) PATIENTS; A SINGLE CENTER RETROSPECTIVE ANALYSIS
    Kato, M.
    Shimada, H.
    Nakashima, S.
    Mansour, M. Mahmoud Fahmy
    Wakiya, R.
    Miyagi, T.
    Sugihara, K.
    Ushio, Y.
    Kameda, T.
    Dobashi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1540 - 1540
  • [4] Low-dose rituximab as induction therapy for ANCA-associated vasculitis
    Yukiko Takakuwa
    Hironari Hanaoka
    Tomofumi Kiyokawa
    Harunobu Iida
    Hisae Fujimoto
    Yoshioki Yamasaki
    Hidehiro Yamada
    Kimito Kawahata
    Clinical Rheumatology, 2019, 38 : 1217 - 1223
  • [5] Low-dose rituximab as induction therapy for ANCA-associated vasculitis
    Takakuwa, Yukiko
    Hanaoka, Hironari
    Kiyokawa, Tomofumi
    Iida, Harunobu
    Fujimoto, Hisae
    Yamasaki, Yoshioki
    Yamada, Hidehiro
    Kawahata, Kimito
    CLINICAL RHEUMATOLOGY, 2019, 38 (04) : 1217 - 1223
  • [6] Single-dose rituximab for remission induction and maintenance therapy in ANCA-associated vasculitis: a retrospective analysis of 17 patients
    Moog, P.
    Probst, M.
    Kuechle, C.
    Hauser, C.
    Heemann, U.
    Thuermel, K.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (06) : 519 - 523
  • [7] PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS
    Gulati, Kavita
    McAdoo, Stephen
    Galliford, Jack
    Griffith, Megan
    Levy, Jeremy
    Cairns, Tom
    Pusey, Charles
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [8] PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS
    Gulati, Kavita
    Mcadoo, Stephen
    Tanna, Anisha
    Levy, Jeremy
    Griffith, Megan
    Cairns, Thomas
    Pusey, Charles
    RHEUMATOLOGY, 2019, 58
  • [9] Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated Vasculitis
    Floyd, Lauren
    Morris, Adam D.
    Shetty, Anamay
    Brady, Mark E.
    Ponnusamy, Arvind
    Warwicker, Paul
    Dhaygude, Ajay
    KIDNEY360, 2023, 4 (09): : 1286 - 1292
  • [10] Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis
    Jayne, David R. W.
    Merkel, Peter A.
    Bekker, Pirow
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1535 - 1535
12345